Shenyang Xingqi Pharmaceutical Co.,Ltd. (SHE:300573)

Market Cap	17.68B
Revenue (ttm)	2.21B
Net Income (ttm)	503.57M
Shares Out	245.35M
EPS (ttm)	2.05
PE Ratio	35.14
Forward PE	n/a
Dividend	1.07 (1.49%)
Ex-Dividend Date	May 22, 2025

Volume	18,031,571
Average Volume	18,684,124
Open	68.70
Previous Close	71.20
Day's Range	68.70 - 72.99
52-Week Range	46.34 - 91.21
Beta	0.19
RSI	61.30
Earnings Date	Aug 28, 2025

About SHE:300573

Shenyang Xingqi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of ophthalmic drug in the People’s Republic of China. The company develops ophthalmic anti-infective drugs, other ophthalmic drugs, nonsteroidal anti-inflammatory drugs for ophthalmology, mydriatic and ciliary muscle paralytic drugs, ophthalmic anti-inflammatory/anti-infective compound drugs, dry eye products, miotic and anti-glaucoma drugs, and other drugs. It also develops products, such as Zirun, a Cyclosporine eye drops; Sugaojie, a calf bl...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1977
• Employees: 2,426
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300573

Financial Performance

In 2024, SHE:300573's revenue was 1.94 billion, an increase of 32.42% compared to the previous year's 1.47 billion. Earnings were 338.06 million, an increase of 40.84%.